Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 205 pembrolizumab 169 Pemetrexed 144 Cisplatin 126 Paclitaxel 78 durvalumab 75 osimertinib 70 Nivolumab 68 Docetaxel 66 Specimen Handling 64 atezolizumab 60 Magnetic Resonance Spectroscopy 54 Etoposide 47 Gemcitabine 46 Radiotherapy 45 Radiosurgery 40 130-nm albumin-bound paclitaxel 36 Drug Therapy 33 Bevacizumab 29 Cetuximab 28 Ipilimumab 27 cemiplimab 25 Taxes 24 tislelizumab 21 Immunoglobulin G 21 Radiation 20 Platinum 20 Biopsy 20 amivantamab 19 Disulfides 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

guadecitabine × Thoracic × 90 days × Clear all

NCT02998567 2026-05-12

HyPeR

Royal Marsden NHS Foundation Trust

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡